Search

Your search keyword '"Aminolevulinic acid -- Intellectual property"' showing total 20 results
Start Over Descriptor "Aminolevulinic acid -- Intellectual property" Topic editors
20 results on '"Aminolevulinic acid -- Intellectual property"'

1. Researchers Submit Patent Application, 'Complexes For Delivery Of Antigenic Peptides', for Approval (USPTO 20200129640)

Subjects
Ipilimumab, Physical fitness, Aminolevulinic acid -- Intellectual property, Marburg virus disease, Atezolizumab -- Intellectual property, Nivolumab, Peptides, Povidone -- Intellectual property, Pembrolizumab, Obesity, Editors, Health
Abstract

2020 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2020

2. Patent Issued for Photosensitising Composition And Its Uses (USPTO 10,568,961)

Subjects
Physical fitness, Aminolevulinic acid -- Intellectual property, Infection, Methylene blue -- Intellectual property, Obesity, Editors, Photochemotherapy, Health
Abstract

2020 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Dentsply Sirona Inc. has been issued patent number 10,568,961, according to news [...]

Published
2020

3. Patent Application Titled 'Pharmaceutical Composition For Preventing Or Treating Cancer' Published Online (USPTO 20190343854)

Subjects
Cancer treatment, Aminolevulinic acid -- Intellectual property, Cancer, Women's health, Cancer prevention, Bevacizumab -- Intellectual property, Artemisinin -- Intellectual property, Carboplatin -- Intellectual property, Nilotinib, Antineoplastic agents -- Intellectual property, Neratinib -- Intellectual property, Decitabine, Lapatinib, Pemetrexed, Health, Vandetanib, Temsirolimus, Cetuximab, Dasatinib, Vincristine, Axitinib, Editors, Sunitinib, Health, Women's issues/gender studies
Abstract

2019 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

4. Patent Issued for Light Irradiation Substrate (USPTO 10,463,875)

Subjects
Physical fitness, Aminolevulinic acid -- Intellectual property, Antibacterial agents -- Intellectual property, Methicillin -- Intellectual property, Obesity, Phototherapy, Editors, Health
Abstract

2019 NOV 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2019

5. Patent Issued for System For Treating A Sebaceous Gland (USPTO 10,449,218)

Subjects
Tetracyclines -- Intellectual property, Physical fitness, Aminolevulinic acid -- Intellectual property, Obesity, Editors, Health
Abstract

2019 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2019

6. Patent Application Titled 'Transdermal Therapeutic System For 5-Aminolevulinic Acid Hydrochloride' Published Online (USPTO 20190240166)

Subjects
Physical fitness, Aminolevulinic acid -- Intellectual property, Transdermal drug delivery systems -- Intellectual property, Amino acids -- Intellectual property, Obesity, Editors, Health
Abstract

2019 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2019

9. Patent Application Titled 'Disease Detection And Treatment Through Activation Of Compounds Using External Energy' Published Online (USPTO 20200147216)

Subjects
Aminolevulinic acid -- Intellectual property, Therapeutics -- Intellectual property, Methylene blue -- Intellectual property, Cancer, Editors, Diseases, Business, Health, Health care industry
Abstract

2020 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

11. 'Therapeutic Agents And Use Thereof' in Patent Application Approval Process (USPTO 20200055934)

Subjects
Aminolevulinic acid -- Intellectual property, Pixantrone -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Immunoglobulins, Sorafenib, Vincristine, Lapatinib, Mitoguazone, Fulvestrant, Editors, Business, Health
Abstract

2020 MAR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors Conlan, Robert (Swansea, GB); Gonzalez, Deyarina (Swansea, [...]

Published
2020

12. Patent Application Titled 'Phototherapeutic Device' Published Online (USPTO 20190374790)

Subjects
Aminolevulinic acid -- Intellectual property, Methicillin -- Intellectual property, Death, Tumors, Editors, Photochemotherapy, Electronics
Abstract

2019 DEC 31 (VerticalNews) -- By a News Reporter-Staff News Editor at Electronics Newsweekly -- According to news reporting originating from Washington, D.C., by VerticalNews journalists, a patent application by [...]

Published
2019

14. Patent Application Titled 'Uses Of Bcl-2 Antagonists For Treating Cancer And Diagnostics Related Thereto' Published Online (USPTO 20190328729)

Subjects
Cabazitaxel, Ixazomib, Ceritinib, Cobimetinib, Ruxolitinib -- Intellectual property, Acalabrutinib -- Intellectual property, Romiplostim -- Intellectual property, Siltuximab, Glucarpidase, Alectinib, Aminolevulinic acid -- Intellectual property, Midostaurin -- Intellectual property, BCR-ABL tyrosine kinase inhibitors, Ramucirumab, Trifluridine -- Intellectual property, Olaparib, Nivolumab, Carboplatin -- Intellectual property, Obinutuzumab, Lanreotide, Methylnaltrexone, Brigatinib -- Intellectual property, Rasburicase -- Intellectual property, Pamidronate -- Intellectual property, Axicabtagene ciloleucel -- Intellectual property, Enasidenib -- Intellectual property, Osimertinib, Palifermin -- Intellectual property, Cancer, Monoclonal antibodies, Pembrolizumab, Inotuzumab ozogamicin -- Intellectual property, Belinostat, Neratinib -- Intellectual property, Zoledronic acid, Decitabine, Copanlisib -- Intellectual property, Durvalumab -- Intellectual property, Palbociclib, Idelalisib, Blinatumomab, Bevacizumab -- Intellectual property, Antiemetics -- Intellectual property, Plerixafor, Abemaciclib -- Intellectual property, Eltrombopag -- Intellectual property, Talimogene laherparepvec, Antineoplastic agents -- Intellectual property, Afatinib, Temsirolimus, Cabozantinib, Fulvestrant, Pertuzumab, Dasatinib, Nelarabine, Axitinib, Ibrutinib, Sonidegib, Nilotinib, Abiraterone, Dabrafenib, Pemetrexed, Pomalidomide, Carfilzomib, Olaratumab, Enzalutamide, Sunitinib, Niraparib, Crizotinib, Necitumumab, Lapatinib, Dinutuximab, Ponatinib, Bosutinib, Rucaparib, Ofatumumab, Sorafenib, Bendamustine, Trametinib, Vemurafenib, Tumors, Ribociclib, Aflibercept, Panobinostat, Cancer treatment, Anopheles, Clofarabine, Ixabepilone, Vincristine, Editors, Lenvatinib, Rolapitant, Vandetanib, Aprepitant, Cetuximab, Atezolizumab, Romidepsin, Ipilimumab, Venetoclax, Trabectedin, Vismodegib, Elotuzumab, Pralatrexate, Regorafenib, Degarelix, Everolimus, Vorinostat, Avelumab, Palonosetron, Panitumumab, Brentuximab vedotin, Ibritumomab tiuxetan, Denosumab, Pazopanib, Daratumumab, Business, Health, Health care industry
Abstract

2019 NOV 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2019

15. Patent Issued for Endoscopic Device Incorporating Diode Laser For PDD, PDT, And AF Applications (USPTO 10,448,817)

Subjects
Aminolevulinic acid -- Intellectual property, Lasers -- Intellectual property, Electronic components -- Intellectual property, Biological markers, Fluorescence, Editors, Semiconductor device, Laser, Business, Health
Abstract

2019 NOV 8 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- KARL STORZ Endovision Inc. (Charlton, Massachusetts, United States) has been issued patent number [...]

Published
2019

16. 'Radiation Damage Protective Agent' in Patent Application Approval Process (USPTO 20190282611)

Subjects
Nuclear power plants -- Intellectual property, Biomedical laboratories, Aminolevulinic acid -- Intellectual property, Romiplostim -- Intellectual property, Nuclear energy -- Intellectual property, Radiation (Physics), Electric power plants, Nuclear facilities, Editors, Workers, Business, Health
Abstract

2019 OCT 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors Aoki, Yukimasa (Tokyo, JP); Hirano, Shinichi (Kanagawa, [...]

Published
2019

18. Researchers Submit Patent Application, 'Boron-Containing Compound', for Approval (USPTO 20190177341)

Subjects
Cancer treatment, Aminolevulinic acid -- Intellectual property, Hydroquinone -- Intellectual property, Amino acids -- Intellectual property, Boron neutron capture therapy, Cancer, Editors, Novels, Business, Health, Health care industry
Abstract

2019 JUL 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Hattori, Yoshihide [...]

Published
2019

20. 'Specific Photoimmuno-Theranostics For Detection And Elimination Of Skin Cancer Cells' in Patent Application Approval Process (USPTO 20190071506)

Subjects
Aminolevulinic acid -- Intellectual property, Skin cancer, Antineoplastic agents, Cancer cells, Editors, Pharmaceuticals and cosmetics industries, Health, Photofrin (Medication) -- Intellectual property
Abstract

2019 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- A patent application by the inventors Barth, Stefan (Cape Town, ZA); Hussain, Ahmad [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results